S
Sensome
An innovative start-up developing a breakthrough remote monitoring technology that can turn invasive medical devices into connected healthcare devices
About Sensome
Sensome, a clinical-stage medtech company, was co-founded in 2014 by Franz Bozsak and Abdul Barakat. The company's origins are rooted in a decade of academic research in biomechanics and micro-acoustics, which led to the development of its proprietary technology.
Read full description
Sensome's core offering is a sensor-powered guidewire designed to assist in the treatment of ischemic stroke. This technology, known as the Clotild Smart Guidewire System, integrates a micro-sensor at the tip of a neurovascular guidewire. This sensor, coupled with predictive analytics, provides physicians with real-time information on the composition of a blood clot, such as whether it is red-blood-cell-rich or fibrin-rich. This information is critical for making informed decisions during mechanical thrombectomy procedures, as the type of clot determines the most effective removal strategy. The system aims to improve the revascularization success rate on the first attempt, thereby enhancing patient outcomes.
The company's business model revolves around the development and commercialization of this smart guidewire system. Its primary market is the neurovascular field, specifically hospitals and clinics that perform ischemic stroke interventions. By providing a tool that can significantly improve the efficacy of these procedures, Sensome aims to become an indispensable part of the stroke treatment workflow.
At a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Massy, France
- Employees
- 40
- Open positions
- None listed
- Dealroom signal
- 67.1/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Non-Invasive medical devices and treatments, Spinout, Vivatech2019, biotech medtech and e-health
- Technology
- Artificial Intelligence, Deep Tech, Computer Vision, Connected Device, Recognition Technology, IoT InternetOfThings
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Sensome.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Jan 2020 | $9M | $36M | Eurazeo · BNP Paribas · Partech · BNP Paribas Développement | ↗ |
| SUPPORT PROGRAM✓Other financing | Nov 2019 | $0 | — | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Sensome is 140 monthly website visits, down 75% over the last three months. Sensome's team declined 4.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 BioSerenityLeading global providers of remote diagnostic solutions |
Paris, France | Operational | 272 | $118M | $358M |
 RobocathInnovative solutions for the treatment of cardiovascular diseases |
Rouen, France | Acquired | |||
 Mensia TechnologiesNon-invasive neurofeedback medical device for the treatment of ADHD and a number of other central nervous system disorders |
Paris, France | Closed | |||
 BOYDSenseBOYDSense - Health monitoring made simple powered by breath |
Toulouse, France | Operational | |||
 OSO-AIImproving well-being and health through AI-based identification of human-related sounds |
Brest, France | Operational | |||
 PixylNeuroimaging AI for Improved Patient Care |
La Tronche, France | Acquired | |||
 Moon SurgicalMoon Surgical, formerly kown as MastOR, aims to augment the surgeon with leaps forward in computer vision, haptics, and robotics |
Paris, France | Operational | |||
 BraintaleAI-powered platform for brain white matter quantification |
Strasbourg, France | Closed |
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
Series A3 investors entered at this stage
BNP Paribas
Asahi Intecc USA
Paris Saclay Seed Fund
Other known investors7 additional known investors
CNRS Innovation
École Polytechnique - IP Paris
French National Centre for Scientific Research - CNRS
IP Paris
Falling Walls Foundation
Helene Peyro-Saint-Paul- SLSacha Loiseau
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sensome on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sensome’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.